Patient‐reported outcomes in a study of human regular U‐500 insulin delivered by continuous subcutaneous insulin infusion or multiple daily injections in patients with type 2 diabetes

Human regular U‐500 insulin (U‐500R) provides both basal and prandial coverage to people with diabetes. As part of the VIVID study, we studied patient‐reported outcomes (PRO) of U‐500R delivered by multiple daily injections (MDI, n = 211) and continuous subcutaneous infusion using a novel U‐500R pum...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jieling, Fan, Ludi, Peng, Xiaomei, Ilag, Liza, Ly, Trang, Johnson, Jennal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756478/
https://www.ncbi.nlm.nih.gov/pubmed/32893428
http://dx.doi.org/10.1111/dom.14191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756478/
https://www.ncbi.nlm.nih.gov/pubmed/32893428
http://dx.doi.org/10.1111/dom.14191

Ejemplares similares